Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Want to earn without upfront costs? Discover ways to earn today without any investment and start boosting your income now.
27,120 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
As signs point to a softer economy in 2026, dividend-focused ETFs can provide ballast. This guide identifies three re...
Despite renewed fatal-accident headlines, Tesla’s core growth story remains intact, with rising deliveries and softwa...
Meta Platforms trades around $630 amid 2026 market volatility, but bulls say rising ad pricing and early AI monetizat...
Bridger Management quietly exited a large Bath & Body Works position in the fourth quarter, selling about 301,000 sha...
A single moment can ripple through your wallet. When Lionel Messi stood beside a world leader at a White House event,...
A detailed look at Seer’s Q1 2026 earnings, the forces shaping growth, and practical moves investors can make now. Le...
Solana is back in the spotlight as network upgrades and institutional interest pick up. The big question for investor...
Insider moves can reveal how company insiders view the path ahead. This guide breaks down what it means when a chief ...
Applied Optoelectronics surged 251% year-to-date on soaring AI data-center demand, while the Invesco Semiconductors E...
Anchorage Digital confirms it holds Strategy’s STRC perpetual preferred stock, marking a high-profile move by a regul...
Oakmark Select adds to discounted stocks in Q4, signaling a shift toward durable earnings as volatility persists. Nyg...